Hydroxyethyl starch inhibits intestinal production of cytokines and activation of transcription factors in endotoxaemic rats

Journal of International Medical Research

Volumn 33, Issue 4, 2005, Pages 379-388

  Lv, R ^a   Zhou, W ^b   Yang, J J ^a   Jin, Y ^a   Xu, J G ^a  

^a NANJING UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Activator protein 1; Hydroxyethyl starch; Inflammatory cytokines; Intestine; Lipopolysaccharide; Nuclear factor kappa B

Indexed keywords

CYTOKINE; HETASTARCH; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYELOPEROXIDASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENDOTOXEMIA; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART RATE; ILEUM; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; RAT; RAT STRAIN; SEPSIS; STATISTICAL SIGNIFICANCE; TISSUE LEVEL;

EID: 23044467830     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000503300403     Document Type: Article

References (18)

1. Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; 1: 355-357.
2. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T: The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 1989; 169: 333-338.
3. Groeneveld AB: Albumin and artificial colloids in fluid management: where does the clinical evidence of their utility stand? Crit Care 2000; 4 (Suppl 2): S16-S20.
4. Nicholson JP, Wolmarans MR, Park GR: The role of albumin in critical illness. Br J Anaesth 2000; 85: 599-610.
5. Hofbauer R, Moser D, Hornykewycz S, Frass M, Kapiotis S: Hydroxyethyl starch reduces the chemotaxis of white cells through endothelial cell monolayers. Transfusion 1999; 39: 289-294.
6. Collis RE, Collins PW, Gutteridge CN, Kaul A, Newland AC, Williams DM, et al: The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study. Intensive Care Med 1994; 20: 37-41.
7. Tian J, Lin X, Zhou W, Xu J: Hydroxyethyl starch inhibits NF-kappaB activation and prevents the expression of inflammatory mediators in endotoxic rats. Ann Clin Lab Sci 2003; 33: 451-458.
8. Tian J, Lin X, Guan R, Xu JG: The effects of hydroxyethyl starch on lung capillary permeability in endotoxic rats and possible mechanisms. Anesth Analg 2004; 98: 768-774.
9. Jiang J, Bahrami S, Leichtfried G, Redl H, Ohlinger W, Schlag G: Kinetics of endotoxin and tumor necrosis factor appearance in portal and systemic circulation after hemorrhagic shock in rats. Ann Surg 1995; 221: 100-106.
10. Lentsch AB, Ward PA: Regulation of inflammatory vascular damage. J Pathol 2000; 190: 343-348.
11. Morse D, Pischke SE, Zhou Z, Davis RJ, Flavell RA, Loop T, et al: Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 2003; 278: 36993-36998.
12. Wang P, Ba ZF, Chaudry IH: Mechanism of hepatocellular dysfunction during early sepsis. Key role of increased gene expression and release of proinflammatory cytokines, tumor necrosis factor and interleukin-6. Arch Surg 1997; 132: 364-370.
13. Wang W, Smail N, Wang P, Chaudry IH: Increased gut permeability after hemorrhage is associated with upregulation of local and systemic IL-6. J Surg Res 1998; 79: 39-46.
14. Kaplan SS, Park TS, Gonzales ER, Gidday JM: Hydroxyethyl starch reduces leukocyte adherence and vascular injury in the newborn pig cerebral circulation after asphyxia. Stroke 2000; 31: 2218-2223.
15. Schmand JF, Ayala A, Morrison MH, Chaudry IH: Effects of hydroxyethyl starch after trauma-hemorrhagic shock: restoration of macrophage integrity and prevention of increased circulating interleukin-6 levels. Crit Care Med 1995; 23: 806-814.
16. Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV: IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 1997; 278: 866-869.
17. De Plaen IG, Tan XD, Chang H, Wang L, Remick DG, Hsueh W: Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet-activating factor and tumour necrosis factor. Br J Pharmacol 2000; 129: 307-314.
18. De Plaen IG, Qu XW, Wang H, Tan XD, Wang L, Han XB, et al: Endotoxin, but not platelet-activating factor, activates nuclear factor-kappaB and increases IkappaBalpha and IkappaBbeta turnover in enterocytes. Immunology 2002; 106: 577-583.